A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring.
about
A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A retrospective examination of ...... f therapeutic drug monitoring.
@en
A retrospective examination of ...... f therapeutic drug monitoring.
@nl
type
label
A retrospective examination of ...... f therapeutic drug monitoring.
@en
A retrospective examination of ...... f therapeutic drug monitoring.
@nl
prefLabel
A retrospective examination of ...... f therapeutic drug monitoring.
@en
A retrospective examination of ...... f therapeutic drug monitoring.
@nl
P2860
P356
P1476
A retrospective examination of ...... f therapeutic drug monitoring.
@en
P2093
Brett Fleisher
Sihem Ait-Oudhia
P2860
P304
P356
10.2147/OTT.S153056
P407
P577
2017-12-27T00:00:00Z